author-photo

J.F.R. Robertson

Nottingham City Hospital

150

Papers

19196

Citations

Citation Trend

Filter By

Papers (150) Sort By

JournalConferenceOthers

Abstract P2-12-01: Dose- and exposure-response relationship and biomarker correlation analysis in breast tumors from patients treated with capivasertib, an AKT inhibitor, in the STAKT randomized, placebo controlled pre-surgical study

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-13-11: Meta-analyses of visceral versus non-visceral metastases treated by SERM, AI & SERD agents as 1st line endocrine therapy (ET) for HR+ breast cancer (BC)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-03-02: Markers of PI3K/Akt, ER & AR pathways and Ki67 expression in relation to tamoxifen outcome in ER+ breast cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD2-04: Baseline circulating ESR1 mutation analysis in the randomised phase III EFECT study of fulvestrant versus exemestane in advanced hormone receptor positive breast cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (14)
Abstract P4-04-06: AZD5363, an AKT inhibitor, significantly inhibits key biomarkers of the AKT pathway and Ki67, in a randomized, placebo, controlled study (STAKT) in human breast cancers

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD5-05: Genomic instability and poor antiproliferative response to aromatase inhibitor treatment: A POETIC study

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-13-01: Withdrawn

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P2-09-02: True effect of aromatase inhibitor (AI) treatment on global gene expression (expr) changes in postmenopausal ER+ breast cancer (BC) patients: A POETIC study (CRUK/07/015)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P2-10-02: The impact of intrinsic subtypes and molecular features on aromatase inhibitor induced reduction of proliferation marker of Ki67 in primary ER+ breast cancer: A POETIC study (CRUK/07/015)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号